Department of Pharmacy, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Intensive Care Unit, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Curr Med Res Opin. 2023 Aug;39(8):1077-1084. doi: 10.1080/03007995.2023.2233826. Epub 2023 Jul 12.
To promote an effective strategy to improve the non-guideline-recommended prescribing (NGRP) of acid suppressive medications for stress ulcer prophylaxis (SUP) in critically ill patients and to evaluate the impact and barriers of a multifaceted intervention on NGRP in critically ill patients.
A retrospective, pre- post-intervention study was performed in the medical-surgical ICU. This study included pre-intervention and post-intervention period. There was no SUP guideline and intervention in the pre-intervention period. In the post-intervention period, the multifaceted intervention included five features: a practice guideline, an education campaign, medication review and recommendations, medication reconciliation, and pharmacist rounding with the ICU team.
A total of 557 patients were studied (305 in the pre-intervention group and 252 in the post-intervention group). Patients who underwent surgery, stayed in ICU more than 7 days, or used corticosteroids experienced significantly higher rate of NGRP in the pre-intervention group. The average percentage of patient days of NGRP was significantly reduced from 44.2% to 23.5% ( .001) by implementing the multifaceted intervention. The percentage of patients with NGRP decreased from 86.7% to 45.5% in terms of all 5 criteria (indication, dosage, IV to PO, duration, and ICU discharge; = .003). Per-patient NGRP cost decreased from $45.1 (22.6, 93.0) to $11.3 (11.3, 45.1; = .004). The main barrier influencing NGRP was the factors of the patient, including the concurrent use of nonsteroidal anti-inflammatory drugs (NSAIDs), the number of comorbidities, and undergoing surgery.
The multifaceted intervention was effective in improving NGRP. Further studies are needed to confirm whether our strategy is cost-effective.
提出一种有效的策略,以改善对重症患者应激性溃疡预防(SUP)的抑酸药物的非指南推荐处方(NGRP),并评估多方面干预对重症患者 NGRP 的影响和障碍。
在外科重症监护病房(SICU)进行了一项回顾性的、干预前后的研究。该研究包括干预前和干预后两个时期。在干预前时期,没有 SUP 指南和干预措施。在干预后时期,多方面干预包括五个特征:实践指南、教育活动、药物审查和建议、药物重整和药剂师与 ICU 团队一起查房。
共研究了 557 例患者(干预前组 305 例,干预后组 252 例)。在干预前组中,接受手术、在 ICU 停留超过 7 天或使用皮质类固醇的患者,其 NGRP 发生率明显更高。通过实施多方面干预,NGRP 的患者天数平均百分比从 44.2%显著降低至 23.5%(<.001)。根据所有 5 项标准(适应证、剂量、IV 到 PO、持续时间和 ICU 出院),NGRP 的患者比例从 86.7%降至 45.5%(=.003)。每位患者的 NGRP 费用从 45.1 美元(22.6,93.0)降至 11.3 美元(11.3,45.1;=.004)。影响 NGRP 的主要障碍是患者因素,包括同时使用非甾体抗炎药(NSAIDs)、合并症数量和手术。
多方面干预措施在改善 NGRP 方面是有效的。需要进一步的研究来确认我们的策略是否具有成本效益。